Literature DB >> 18181726

Probiotics in the United States.

Jon A Vanderhoof1, Rosemary Young.   

Abstract

Probiotics are live microbial products that have a defined health benefit. Scientific research has established that there are validated indications for the use of some probiotics available in the United States; however, in many cases, they are often used for conditions for which no benefit has been established. This article will review the uses of probiotics in the United States, as well as the current state of regulatory issues surrounding probiotics. Although the use and scientific understanding of probiotics are rapidly increasing, it is evident that there is a need to clarify the regulatory issues, which, at present, are unclear and subject to misinterpretation. In addition to efficacy, safety issues must be considered in determining when and how probiotics are to be used.

Mesh:

Year:  2008        PMID: 18181726     DOI: 10.1086/523339

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndrome.

Authors:  MaryBeth Mercer; Margaret A Brinich; Gail Geller; Krista Harrison; Janelle Highland; Katherine James; Patricia Marshall; Jennifer B McCormick; Jon Tilburt; Jean-Paul Achkar; Ruth M Farrell; Richard R Sharp
Journal:  J Clin Gastroenterol       Date:  2012-02       Impact factor: 3.062

3.  Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine.

Authors:  Yuying Liu; Nicole Y Fatheree; Nisha Mangalat; Jon Marc Rhoads
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-29       Impact factor: 4.052

4.  Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.

Authors:  Yuying Liu; Nicole Y Fatheree; Nisha Mangalat; Jon Marc Rhoads
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-26       Impact factor: 4.052

Review 5.  Kombucha: Perceptions and Future Prospects.

Authors:  Patrícia Batista; Maria Rodrigues Penas; Manuela Pintado; Patrícia Oliveira-Silva
Journal:  Foods       Date:  2022-07-04

6.  The increase of Lactobacillus species in the gut flora of newborn broiler chicks and ducks is associated with weight gain.

Authors:  Emmanouil Angelakis; Didier Raoult
Journal:  PLoS One       Date:  2010-05-04       Impact factor: 3.240

7.  Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations.

Authors:  S A Cohen; M C Woodfield; N Boyle; Z Stednick; M Boeckh; S A Pergam
Journal:  Transpl Infect Dis       Date:  2016-09-21       Impact factor: 2.228

8.  Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial.

Authors:  Luz A González-Hernández; Luis F Jave-Suarez; Mary Fafutis-Morris; Karina E Montes-Salcedo; Luis G Valle-Gutierrez; Ariel E Campos-Loza; Luis Fermin Enciso-Gómez; Jaime F Andrade-Villanueva
Journal:  Nutr J       Date:  2012-10-29       Impact factor: 3.271

Review 9.  Probiotics in the management of lung diseases.

Authors:  Esmaeil Mortaz; Ian M Adcock; Gert Folkerts; Peter J Barnes; Arjan Paul Vos; Johan Garssen
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

10.  The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H.pylori: a randomized controlled trial.

Authors:  Homayoun Zojaji; Mehdi Ghobakhlou; Hassan Rajabalinia; Elnaz Ataei; Somayeh Jahani Sherafat; Bijan Moghimi-Dehkordi; Rasoul Bahreiny
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.